European Neuropsychopharmacology provides a medium for the prompt publication of articles in the field of neuropsychopharmacology in its broadest sense. Full length Research Papers of original experimental or clinical research max 4000 words (including tables and legends to figures) and more than 30 references; Short Communications: same as full length research max 2000 words; Reviews on specialised topics no words limit. Letters to the Editor can be related or not to material published in the journal but are limited to 300 words and 5 references.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 6.1 |
| 2022 | 5.6 |
| 2021 | 5.415 |
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 0924-977X, 1990-ongoing, Medicine,Neuroscience,Pharmacology, Toxicology and Pharmaceutics.